Top

Published in:

01-05-2019 | Literatur kommentiert

Einfluss der prophylaktischen Ganzhirnbestrahlung auf das Gesamtüberleben von Patienten mit einem fortgeschrittenen nicht-kleinzelligen Bronchialkarzinom

Authors: Julia Schmidt, Dr. med. Steffen Appold, Prof. Dr. med. Esther G. C. Troost

Published in: Strahlentherapie und Onkologie | Issue 5/2019

Auszug

In einer randomisierten Phase-III-Studie sollte untersucht werden, ob eine prophylaktische Ganzhirnbestrahlung bei kurativ-intendiert behandelten Patienten mit einem nicht-kleinzelligen Bronchialkarzinom (NSCLC) im Stadium III Einfluss auf das Auftreten von symptomatischen Hirnmetastasen hat. …

Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M et al (2017) Durvalumab after Chemoradiotherapy in stage III non-small-cell lung cancer. N Engl J Med 377:1919–1929CrossRefPubMed

Aupérin A, Arriagada R, Pignon JP, Le Péchoux C, Gregor A, Stephens RJ, Kristjansen PE, Johnson BE, Ueoka H, Wagner H, Aisner J, Prophylactic Cranial Irradiation Overview Collaborative Group (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 341:476–484CrossRefPubMed

Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial. Lancet Oncol 10:1037–1044CrossRefPubMed

De Ruysscher D, Dingemans A‑MC, Praag J, Belderbos J, Tissing-Tan C, Herder J, Haitjema T, Ubbels F, Lagerwaard F, El Sharouni SY, Stigt JA, Smit E et al (2018) Prophylactic cranial irradiation versus observation in radically treated stage III non-small-cell lung cancer: A randomized phase III NVALT-11/DLCRG-02 study. J Clin Oncol 36:2366–2377CrossRefPubMed

Le Péchoux C, Dunant A, Senan S, Wolfson A, Quoix E, Faivre-Finn C, Ciuleanu T, Arriagada R, Jones R, Wanders R, Lerouge D, Laplanche A et al (2009) Standard-dose versus higher-dose Prophylactic Cranial Irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): A randomised clinical trial. Lancet Oncol 10:467–474CrossRefPubMed

Oehlke O, Wucherpfennig D, Fels F, Frings L, Egger K, Weyerbrock A, Prokic V, Nieder C, Grosu A‑L (2015) Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: Local tumour control and survival. Strahlenther Onkol 191:461–469CrossRefPubMed

Pöttgen C, Eberhardt W, Grannass A, Korfee S, Stüben G, Teschler H, Stamatis G, Wagner H, Passlick B, Petersen V, Budach V, Wilhelm H et al (2007) Prophylactic cranial irradiation in operable stage III A non small-cell lung cancer treated with neo adjuvant chemo radiotherapy: Results from a German multicenter randomized trial. J Clin Oncol 25(31):4987–4992. https://doi.org/10.1200/jco.2007.12.5468 CrossRefPubMed

Prokic V, Wiedenmann N, Fels F, Schmucker M, Nieder C, Grosu A‑L (2013) Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: A planning study on treatment concepts. Int J Radiat Oncol Biol Phys 85:264–270CrossRefPubMed

Russell AH, Pajak TE, Selim HM, Paradelo JC, Murray K, Bansal P, Cooper JD, Silverman S, Clement JA (1991) Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: Results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 21:637–643CrossRefPubMed

10.

Tsakonas G, De Petris L, Ekman S (2017) Management of brain metastasized non-small cell lung cancer (NSCLC) – From local treatment to new systemic therapies. Cancer Treat Rev 54:122–131CrossRefPubMed

11.

Yamamoto M, Serizawa T, Higuchi Y, Sato Y, Kawagishi J, Yamanaka K, Shuto T, Akabane A, Jokura H, Yomo S, Nagano O, Aoyama H (2017) A multi-institutional prospective observational study of Stereotactic Radiosurgery for patients with multiple brain metastases (JLGK0901 study update): Irradiation-related complications and long-term maintenance of mini-mental state examinationscores. Int J Radiat Oncol Biol Phys 99:31–40CrossRefPubMed

Title: Einfluss der prophylaktischen Ganzhirnbestrahlung auf das Gesamtüberleben von Patienten mit einem fortgeschrittenen nicht-kleinzelligen Bronchialkarzinom
Authors: Julia Schmidt
Dr. med. Steffen Appold
Prof. Dr. med. Esther G. C. Troost
Publication date: 01-05-2019
Publisher: Springer Berlin Heidelberg
Published in: Strahlentherapie und Onkologie / Issue 5/2019
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-019-01443-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Einfluss der prophylaktischen Ganzhirnbestrahlung auf das Gesamtüberleben von Patienten mit einem fortgeschrittenen nicht-kleinzelligen Bronchialkarzinom

Auszug

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Auszug

Please log in to get access to this content

Other articles of this Issue 5/2019

Endokrine Funktionsstörungen nach Bestrahlung von Hirntumoren bei Kindern und jungen Erwachsenen

Dosimetric and volumetric effects in clinical target volume and organs at risk during postprostatectomy radiotherapy

Impact of androgen deprivation therapy on apparent diffusion coefficient and T2w MRI for histogram and texture analysis with respect to focal radiotherapy of prostate cancer

Institutional patient accrual volume and the treatment quality of I‑125 prostate seed implantation in a Japanese nationwide prospective cohort study

Toxicity and risk factors after combined high-dose-rate brachytherapy and external beam radiation therapy in men ≥75 years with localized prostate cancer

Chemoradiotherapy for anal cancer: are we as good as we think?